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a b s t r a c t
Susac's Syndrome (SS) is a rare, autoimmune angiopathy characterized by hearing loss,
retinal artery occlusions and encephalopathy, which is usually expressed in multifocal
neurological signs and symptoms, confusion state and cognitive impairment. There have
been few descriptions of neuropsychological assessment of SS.
We present a case study of 29-year-old woman who developed full SS. During the post-
acute stage of disease, she was admitted to neurorehabilitation ward to improve her
cognitive-behavioral and motor functioning. The initial assessment revealed attention,
memory and executive dysfunctions, as well as behavioral changes including impulsivity,
affective dysregulation and reduced self-awareness of disease deﬁcits.
After ﬁve weeks recovery process supported by rehabilitation program, improvement
was observed, although some cognitive-behavioral deﬁcits were still present in the follow-
up assessment.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
Available online at www.sciencedirect.com
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Susac's Syndrome (SS) is an autoimmune disease ﬁrst
described in 1979 by an American neurologist John Susac. It
is a rare underdiagnosed endotheliopathy. Clinically, the full
syndrome includes a triad of symptoms: encephalopathy,
branch retinal artery occlusion (BRAOs) and hearing loss [1].
Typical ﬁndings in magnetic resonance imaging (MRI), are
lesions localized in the central portion of the corpus callosum
and in another sites of white and deep gray matter, as well as
leptomeninges enhancement [1,2]. All components of the* Corresponding author at: 2nd Department of Neurology, Institute of 
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take years for all of them to evolve [2]. SS occurs mainly in
female population, especially between 20 and 40 years old. It
can be diagnosed on the base of clinical triad listed above,
conﬁrmed by cerebrospinal ﬂuid analysis, MRI and PET
characteristics, audiometry and retinal ﬂuorescein angiogra-
phy. Brain pathology demonstrates microinfarcts with loss of
neurons, axons, and myelin in both white and deep gray
matter [3]. The presence of anti-endothelial cell antibodies
(AECAs) may have a pathogenic role in the disease [4]. The
clinical course of SS can be ﬂuctuating, but usually self-limited
and monophasic. However, aggressive and sustained immu-Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland.
del@ipin.edu.pl (T. Mendel),
du.pl (J. Seniów).
p. z o.o. All rights reserved.
Fig. 1 – MRI revealed the presence of snowball lesions in the
corpus callosum (A) - FLAIR, punched out holes in the corpus
callosum (B) - T1, strings of pearls in posterior part of the
capsula interna (C) - DWI.
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irreversible neurological symptoms, hearing and vision loss.
Symptoms usually last between six months to ﬁve years, but
can reappear after many years, therefore SS requires lifelong
monitoring [5,6]. Encephalopathy in SS results from an acute or
subacute multifocal brain damage and may be subclinical or
dominating in the clinical picture. Its severity does not
correlate with the severity of initial neurological symptoms,
and tends to be mild in the majority [7]. It occurs in 60–70% of
SS patients and can manifest itself as major deﬁcits in various
cognitive domains, at the beginning of the disease co-
occurring with confusion and/or personality changes, bizarre
behavior, mood disturbances, and even psychotic symptoms;
features of abulia can also be present and may progress to a
stage where verbal and nonverbal communication is no longer
possible [8]. However, until today, only ﬁve articles have
described in detail neuropsychological dysfunctions in SS [9].
Cognitive impairments and their severity probably vary in
individual patients: some studies have described mainly
psycho-motor slowness, while others indicated more speciﬁc
symptoms in domain of memory, attention, and executive
functioning. Recently, comprehensive neuropsychological
assessment was provided by Le Monda et al. [9]. In this case
report a patient examined two years after the SS's onset,
presented some cognitive inefﬁciencies, including visuo-
constructive disability, difﬁculty of encoding of a wordlist
and limited set-shifting. There was, however, no evidence of
signiﬁcant memory disturbance.
We present a case study of 29-year-old woman who
developed full SS and underwent a detailed neuropsychologi-
cal assessment and rehabilitation, so it can contribute to the
existing literature on this rare syndrome. In the presented
case, the cognitive-behavioral disturbances only partly resem-
ble these descripted by Le Monda et al. [9], which also suggests
the possible individual differences in the neuropsychological
proﬁle of encephalopathy in SS.
2. Case report
A 29 year old, right-handed woman began to suffer from
migraine-like headaches in June 2015. According to the family
interview, after a few weeks a progressive cognitive decline,
behavioral disturbances (personality changes, apathy) as well
as subacute hearing loss, tinnitus, dizziness, vertigo, visual
blurring, fatigue, dysarthria, unsteady gait, ataxia, leg weakness
and falls appeared. A few weeks later, double vision, further
hearing loss and dysphagia occurred. The patient was
hospitalized in a neurology department. Neurological exami-
nation revealed preserved consciousness, full auto- and
alloorientation, central nerve VII right paresis, slight hearing
loss bilaterally, slight spastic paraparesis of low extremities
(more pronounced on the right side – 4 points in Medical
Research Council scale for muscle strength (MRC scale),
Babinski sign on the right side, gait unstability and visual
acuteness twenty twenty (correct). Two months since the ﬁrst
disease symptoms, ﬁnal diagnosis of encephalopathic form of
SS was established. For the diagnosis of the SS a signiﬁcant
examination was – among others – MRI, which showed
typical ﬁndings. Sagittal T2 FLAIR revealed a multiple typical
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corpus callosum; saggital T1 – a callosal ‘‘holes’’; Axial DWI –
‘‘string of pearls’’ – like lesions in the posterior limb of the
internal capsule (Fig. 1). Audiometry demonstrated bilateral
sensorineural hearing loss, more pronounced on the right side.
Retinal ﬂuorescein angiography revealed branch retinal artery
occlusion, vessels wall hyperﬂuorescence and ‘‘leakage’’ of dye.
The patient was treated seven daily 1 g IV pulses of
methylprednisolone, followed immediately by oral prednisone
60 mg daily. Heparin in therapeutic doses was also adminis-
tered for one month. After four weeks hospitalization in the
neurology department, the patient was admitted to a rehabili-
tation ward for attempts to improve her cognitive-behavioral
and motor functioning. During a ﬁve-week recovery process
supported by rehabilitation program, including physioterapeu-
tic and neuropsychological therapies, the patient's clinical state
gradually improved, spastic paraparesis withdrew and gait
returned to normal state. The patient was discharged on a daily
dose of 40 mg of prednisone and 75 mg of salicylic acid.
2.1. Neuropsychological assessment
Neuropsychological assessment was conducted on admission
to neurorehabilitation ward and repeated just after comple-
tion of the therapeutic program. From the family interview it
was known that the patient had no signiﬁcant difﬁculties with
intellectual/cognitive functioning before the current disease.
In childhood her psychomotor development was proper. She
has graduated from a secondary school (economics), with good
grades. For the past eight years she was living in Great Britain,
successfully working as a manager of guesthouse employees.
She came back to Poland because of health problems. The
patient was married and had no children. During the clinical
interview, she complained about some minor attention and
memory difﬁculties and denied any signiﬁcant mood or
behavioral changes. She cooperated well during the psycho-
logical assessment. According to brief cognitive screening test
(Addenbrooke's Cognitive Examination-III – ACE-III [10]) the
criteria of dementia were not met (the patient received
borderline test score, see Table 1). In the next step, the
patient's intellectual functioning was assessed by Wechsler
Adult Intelligence Scale-revised (WAIS-R), which can reveal
more subtle deﬁcits than cognitive screening scales, give
information about the overall level of intellectual functioning,
the presence or absence of signiﬁcant intellectual disability,
and provide clues to altered functions [11]. In that measure-
ment tool the patient scored in the borderline range according
to expected norms for age (see Table 1). She had major
difﬁculties and slow reactions at analysing and processing
information, especially concerning visual tasks. Performance
at most verbal tasks in WAIS-R (without time limit), was within
low average, however the ability to recall general information
(knowledge acquired premorbidly: WAIS-Information) was
mildly compromised. Slow learning and low ability to solve a
task demanding visual-motor interaction was also noticed
(e.g. Digit Symbol). Particular cognitive weaknesses emerged at
the tasks in which complex problem solving, working memory
and logical reasoning were especially required (e.g. Arithmetic,
Picture Arrangement). Selected neuropsychological tests were
performed in further assessment (see Table 1), as well asnumerous non-standardized clinical tasks. The ecological,
behavioral tests (e.g. Rivermead Behavioural Memory Test
(RBMT-III), Test of Everyday Attention (TEA), Behavioural
Assessment of Dysexecutive Syndrome (BADS) were also used,
however because of lack of Polish norms, their scores could be
interpreted mainly clinically. Results of the examination
indicated following moderate dysfunctions:
- poor visuoconstruction ability (mostly due to slow proces-
sing and impaired planning – e.g. in Rey Complex Figure Test
(copy),
- attention deﬁcits (impaired sustained, selective and divided
attention, as well as attentional switching – TEA, Trail
Making Test),
- executive dysfunction (impaired planning, set shifting and
new problem solving ability, tendency toward impulsive,
inappropriate reactions and limited use of feedback – BADS,
Wisconsin Card Sorting Test, Tower of London),
- mild memory disturbance (diminished effectiveness of
learning new information with delayed recall, limited face
recognition after short delay, short-term visual memory (e.g.
RBMT-III, Benton Visual Retention Test, California Verbal
Learning Test, Rey Complex Figure Test (recall),
- reduced efﬁciency of logical reasoning (diminished abstrac-
tion and generalization as well as inferring cause-and-effect
relationships (e.g. Wisconsin Card Sorting Test, Picture
Arrangement).
Visual perception, examined by clinical agnosia tasks (e.g.
objects detection and recognition), was correct. Speech was
not overtly impaired, although some slight change in
articulation was reported by the patient and her family;
occasional mild word-ﬁnding difﬁculties were also noted
during conversations. The patient was partly aware of her
disease deﬁcits, however, according to the individual inter-
view and Dysexecutive Questionnaire (DEX) scores, she
underestimated some executive dysfunctions (e.g. difﬁculties
in planning ability, impulsiveness) and their inﬂuence on her
everyday functioning. The patient's husband reported some
behavioral changes in natural situations, including emotional
lability, tendencies toward socially inappropriate reactions,
affective dysregulation with occasional inadequate euphoria.
Neuropsychological rehabilitation was implemented, in-
cluding psychoeducation (about the nature and consequences
of the disease) and individual cognitive-behavioral therapeutic
training (60–90 min daily). The last was focused mainly on
attention, planning, organizing and problem solving abilities,
as well as memory strategies (concerning encoding and
retrieval of information). The computer-based training (Reha
Com, Cogni Plus systems) as well as conventional cognitive
exercises with elements of psychological, emotional support
were implemented.
Clinical improvement was noticed and follow-up assess-
ment, conducted after ﬁve weeks (5 months after the disease
onset), revealed better performance at almost all memory
tasks, however there were persisting difﬁculties with face
memorizing and detailed current orientation in time and
space, as well as with semantic information retrieval.
Recognition of verbal information has also improved, but at
the same time, a tendency toward false positive errors has
Table 1 – The results of initial neuropsychological assessment and the follow up after 5 weeks of neuropsychological
rehabilitation (main scores).
Neuropsychological test Pre-test Post-test
The Addenbrooke's Cognitive Examination-III (raw scores/maximum) 87/100 (borderline) 92/100 (normal)
Attention 14/18(below average) 17/18 (average)
Memory 25/26 (average) 25/26 (average)
Verbal Fluency 10/14 (low average) 9/14 (below average)
Language 23/26 (low average) 25/26 (average)
Visuospatial Abilities 15/16 (average) 16/16 (average)
Wechsler Adults Intelligence Scale-Revised
Full-Scale IQ 77 (below average)
Verbal IQ 89 (average)
Performance IQ 62 (below average)
Verbal Tests standard stores
Information 7 (below average)
Digit Span 10 (average)
Vocabulary 8 (average)
Arithmetic 5 (low score)
Comprehension 11 (average)
Similarities 8 (average)
Performance Tests standard stores
Picture Completion 5 (low score)
Picture Arrangement 5 (low score)
Block Design 4 (very low score)
Object Assembly 4 (very low score)
Digit Symbol 3 (very low score)
Rey Complex Figure Test (percentiles)
Copy ≤1 (very low score) ≥16% (normal score)
Immediate Recall 3 (very low score) 79 (above average)
Benton Visual Retention Test (results and expected scores)
Number Correct Score 5 (8) (low score) 5 (2) (low score)
Number Errors Score 8 (8) (normal) 6 (2) (low score)
Trial Making Test (percentiles)
Part A 75 (<10) (very low score) 48.3 (10–25) (below average)
Part B 243(<10)(very low score) 155 (<10) (very low score)
California Verbal Learning Test (sten scores)
Total Trials 1–5 4 (low average) 5 (average)
List B Recall 3 (low score) 10 (high score)
Short – Delay Free Recall 4 (low average) 5 (average)
Short – Delay Cued Recall 6 (average) 3 (low score)
Long – Delay Free Recall 6 (average) 6 (average)
Long – Delay Cued Recall 5 (average) 6 (average)
Free Recall Intrusions 10 (high score) 10 (high score)
Recognition Hits 4 (low average) 5 (average)
Recognition Faults 10 (high score) 4 (low average)
Wisconsin Card Sorting Test (percentiles)
Total Number of Incorrect Responses 5 (low score) 34 (low average)
Perseverative Responses 1 (very low score) 7 (low score)
Perseverative Errors 1 (very low score) 21 (low average)
Non-Perseverative Errors 47 (average) 42 (average)
Percentage Conceptual Level Responses 6 (low score) 45 (average)
Number of Categories Achieves 6–10 (low score) 11–16 (moderately low score)
Learning to Learn 2–5 (low score) >16 (normal)
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most aspects, however not in terms of divided attention and
its switching. These problems could have probably secondarily
inﬂuenced other cognitive processes which was noticeable,
among others, as inconsistent performance, signiﬁcantly
worse in dual or rapidly changing tasks. Executive functions,
such as planning and new problem solving have alsoimproved, but mild problems with set-shifting, organizing
and monitoring of complex activity were still observed in
natural situations. Subjectively the patient felt signiﬁcant
improvement of her everyday functioning, which was also
reported by family members. Most of the somatic symptoms
(like nausea) resolved, motor impairment decreased and the
patient became more active. During follow-up assessment, she
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affective behaviors (e.g. occasional euphoria or irritability,
inadequacy in social contacts).
3. Conclusion
To date, only several individual SS case studies presented in
literature included neuropsychological assessment. These
few conﬁrmed interindividual cognitive variability. General-
ly, it seems there is no one cognitive-behavioral picture which
might help clinicians to diagnose SS. There are no such
pathognomonic cognitive subcortical features also in other
cerebral microangiopaties or in multiple sclerosis, that might
help clinicians to recognize a speciﬁc disease. Cognitive-
behavioral global impairment or focal deﬁcits usually depend
on brain damage location and its volume [11]. In our SS
patient, despite characteristic focal lesions in corpus callo-
sum, typical callosal disconnection syndrome (e.g. bimanual
discoordination, alien hand, ideomotor apraxia, tactile
anomia and agraphia in the left hand) was not observed.
Although, her executive dysfunctions and behavioral changes
might be interpreted cautiously as a frontal callosal discon-
nection symptoms. During the acute stage of the disease the
presented patient was suffering from severe encephalopathy,
including primary confusional state. When consciousness
disorders disappeared, executive deﬁcits and some non-
speciﬁc cognitive symptoms, including deﬁcits of various
subsystems of attention, as well as generalized memory
difﬁculties and psychomotor slowing were observed. It is
worth to be noticed that similar symptoms are frequently
reported in small-vessel diseases (SVD), when multifocal or/
and diffused brain pathology occurs. Some studies indicated
that SVD patients display some cognitive and executive
disturbances, e.g. limited speed and precision of perception,
processing information as well working memory/attention
impairment [12]. The suggested mechanism of this multiple-
domain impairment in SVD is a functional disruption of
cortico-subcortical circuits regulating cognition including
memory-related loops (e.g. hippocampal-anterior thalamic
axis loop); frontal hypometabolism observed in neuroimaging
might also be a reason of generalized cognitive deterioration
in such cases. [13]. Concerning our patient's education level
and premorbid social functioning, her cognitive-behavioral
decline as an effect of SS was highly probable. A need for
neuropsychological rehabilitation was also fully justiﬁed. The
new contribution of our paper is applying rehabilitation
program during recovery process, which might improve
outcomes, although in an individual case it is difﬁcult to
clearly prove. In three months the patient's psychological
state and neurological symptoms mostly improved. However,
recovery was not complete and its ﬁnal effect was difﬁcult to
predict. It is known from the literature that some patients
generally recover, having slight residual symptoms or even
not revealing any, but others remain signiﬁcantly impaired, in
cognitive domain, suffering from gait disturbance or hearing
loss. In one research project, aiming to describe SS long-term
consequences, neuropsychological symptoms were present
at the last follow-up assessment 64% of patients, and their
clinical states were recognized by different clinicians as:'encephalopathy', 'mild psycho-organic syndrome', 'fatigue',
'disorientation', 'mnestic deﬁcits' or 'cognitive impairment';
median disease duration was 4.5 years [14]. Still, there is a lack
of long term observations of large group of SS patients,
especially in the aspect of detailed cognition and behavior
descriptions. Screening cognitive measurement tools (e.g.
Mini Mental State Examination) in assessment of SS patients
may not be sensitive enough: a detailed neuropsychological
examination, based also on ecological valid tests, should be
carried out to reveal speciﬁc, often mild cognitive-behavioral
deﬁcits. This disease affects mostly young people whose
return to their social roles remains a great matter of concern.
Therefore, special value is the search for optimal forms of
their rehabilitation both focused on the restoration of
disturbed functions and compensation of permanent deﬁcits
in the chronic stage of disease.
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